glp 1 blood clots Do GLP-1 Drugs Cause Clots? Evidence and Guidance Can GLP-1 Medications Be Considered

Writing original draft: GMT

All three medications are designed to help with diabetes and weight management, with semaglutide as their main ingredient

The human gut, or gastrointestinal tract, is the bodys largest digestive and immune organ

The decision to use tirzepatide in MS patients should be based on: Presence of appropriate indications (type 2 diabetes or obesity with BMI 30 kg/m or 27 kg/m with weight-related comorbidity) Absence of contraindications Patient-specific factors including MS disease activity, functional status, and treatment goals Coordination between neurology and primary care/endocrinology teams Future research priorities should include prospective observational studies examining metabolic medication safety and efficacy in MS cohorts, as well as exploratory studies investigating whether weight loss and metabolic optimization influence MS disease trajectories

Technology platforms for extended release Beyond molecular half-life extension, there is interest in drug delivery platforms